
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
 "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" lang="en">

<head>
<meta name="google-site-verification" content="tpATPqNEN3HXiSbtqevBE9NdgbuCiN9Vmr6EP94lx6w" />
<meta name="keywords" content="OIG Online Portfolio: Drug Pricing and Reimbursement" />
<meta name="description" content="OIG Online Portfolio: Drug Pricing and Reimbursement" />
<title>OIG Online Portfolio: Drug Pricing and Reimbursement | Portfolio  | Reports & Publications | Office of Inspector General | U.S. Department of Health and Human Services</title>
<!--#include virtual="/layout/head.asp" -->




<link rel="stylesheet" type="text/css" href="./tabs.css" />
<script type="text/javascript" src="./stepcarousel.js">



/***********************************************
* Step Carousel Viewer script- (c) Dynamic Drive DHTML code library (www.dynamicdrive.com)
* Visit http://www.dynamicDrive.com for hundreds of DHTML scripts
* Please keep this notice intact
***********************************************/

</script>

<style type="text/css">

.stepcarousel{
position: relative; /*leave this value alone*/
overflow: scroll; /*leave this value alone*/
width: 585px; /*Width of Carousel Viewer itself*/
height: 240px; /*Height should enough to fit largest content's height*/
-webkit-box-sizing: border-box; /* set box model so container width and height value includes any padding/border defined */
-moz-box-sizing: border-box;
box-sizing: border-box;
}

.stepcarousel .belt{
position: absolute; /*leave this value alone*/
left: 0;
top: 0;
}

.stepcarousel .panel{
float: left; /*leave this value alone*/
overflow: hidden; /*clip content that go outside dimensions of holding panel DIV*/
margin: 0; /*margin around each panel*/
width: 150px; /*Width of each panel holding each content. If removed, widths should be individually defined on each content DIV then. */
}

span.paginatecircle{ /* CSS for paginate circle spans. Required */
background: white;
border: 2px solid black;
border-radius: 10px;
width: 6px;
height: 6px;
cursor: pointer;
display: inline-block;
margin-right: 4px;
}

span.paginatecircle:hover{
background: gray;
}

span.paginatecircle.selected{
background: black;
}

/* .caption {position:absolute; z-index:10; top:140px; left:0; width:125px;} */
.caption {width:125px; padding-left:4px; line-height:1.1}

.no-bg-exit {background-image:none !important;}

.acc_trigger {cursor:pointer; font-size:10pt;}

</style>



<script type="text/javascript">

stepcarousel.setup({
	galleryid: 'mygallery', //id of carousel DIV
	beltclass: 'belt', //class of inner "belt" DIV containing all the panel DIVs
	panelclass: 'panel', //class of panel DIVs each holding content
	autostep: {enable:true, moveby:1, pause:2000},
	panelbehavior: {speed:500, wraparound:true, wrapbehavior:'slide', persist:true},
	defaultbuttons: {enable: true, moveby: 1, leftnav: ['/fraud/child-support-enforcement/images/prev.gif', -5, 80], rightnav: ['/fraud/child-support-enforcement/images/next.gif', -12, 80]},
	statusvars: ['statusA', 'statusB', 'statusC'], //register 3 variables that contain current panel (start), current panel (last), and total panels
	contenttype: ['inline'] //content setting ['inline'] or ['ajax', 'path_to_external_file']
})


</script>





<!-------------/ head closes and body opens / --->

<!--#include virtual="/layout/head-body-tags.asp" -->

<!------------/ head closes and body opens / --->


<div id="bodyContainer">
	<div id="textReset">
	<!--#include virtual="/layout/header.asp" -->
			<div id="mainBody">
			<div id="leftSideInterior">
				<div id="breadcrumbs">
					<ul>
						<li>
							<a href="/">Home</a>
						</li>
						<li>
							<a href="/reports-and-publications/index.asp">Reports &amp; Publications</a>
						</li>
					
						<li>
						  Portfolio and Other Reports
						</li>
					
					</ul>
				</div>
				<div id="leftContentInterior">



				<h1 id="port">OIG Online Portfolio: Drug Pricing and Reimbursement</h1>

<p style="margin-bottom:20px;">This online portfolio pulls together the Office of Inspector General's (OIG) body of work since 2010 plus several older relevant items that relate to drug pricing and reimbursement in HHS programs. The portfolio features planned work, completed reports, industry guidance, and enforcement actions. This portfolio does not cover OIG's body of work focused on questionable or fraudulent billing for prescription drugs. This portfolio on drug pricing and reimbursement will be updated periodically.</p>          
          

<div id="tab-top">
<ul>
<li><a href="./index.asp#mainBody">Overview</a></li>
<li><a href="./reports.asp#mainBody">Reports</a></li>
<li><a href="./impact.asp#mainBody">Impact</a></li>
<li><a href="./recommendations.asp#mainBody">Recommendations</a></li>
<li><a href="./enforcement.asp#mainBody">Enforcement</a></li>
<li id="selected"><a href="./guidance.asp#mainBody">Industry Guidance</a></li>
</ul>
</div>



<div id="tab-container">

<h2>Industry Guidance</h2>

<div id="tab-interior">
<p>The Federal anti-kickback statute<sup>1</sup>makes it a criminal offense to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce or reward referrals of items or services reimbursable by a Federal health care program. Where remuneration is paid purposefully to induce or reward referrals of items or services payable by a Federal health care program, the anti-kickback statute is violated.  In addition, the civil monetary penalty provision prohibiting inducements to beneficiaries (the CMP)<sup style="vertical-align:middle; position:relative; top:-5px">2</sup>against any person who gives something of value to a beneficiary of Medicare or a State health care program (including Medicaid) that the benefactor knows or should know is likely to influence the beneficiary's selection of a particular provider, practitioner, or supplier of any item or service for which payment may be made, in whole or in part, by Medicare or a State health care program (including Medicaid).  </p>

<p>The resources below provide guidance on OIG's interpretation and enforcement of these statutes in the context of drug pricing and reimbursement. </p> 



<ul>
<li><a href="https://oig.hhs.gov/compliance/alerts/guidance/policy-10302015.pdf">OIG Policy Statement Regarding Hospitals That Discount or Waive Amounts Owed by Medicare Beneficiaries for Self-Administered Drugs Dispensed in Outpatient Settings</a> (October 29, 2015) This document assures hospitals that they will not be subject to OIG administrative sanctions for discounting or waiving amounts that Medicare beneficiaries may owe for self-administered drugs they receive in outpatient settings when those drugs are not covered by Medicare Part B, subject to certain specified conditions.</li>

<li><a href="https://oig.hhs.gov/fraud/docs/alertsandbulletins/2014/SAB_Copayment_Coupons.pdf">Special Advisory Bulletin: Pharmaceutical Manufacturer Copayment Coupons</a> (September 16, 2014) This special advisory bulletin was issued concurrently with a <a href="https://oig.hhs.gov/oei/reports/oei-05-12-00540.asp">report</a> that analyzed the measures pharmaceutical manufacturers use to prevent their coupon programs from inducing the purchase of drugs paid for by Medicare Part D. </li>

<li><a href="https://oig.hhs.gov/fraud/docs/alertsandbulletins/2005/2005PAPSpecialAdvisoryBulletin.pdf">Special Advisory Bulletin: Patient Assistance Programs for Medicare Part D Enrollees</a> (November 7, 2005) and <a href="https://oig.hhs.gov/fraud/docs/alertsandbulletins/2014/independent-charity-bulletin.pdf">Supplemental Special Advisory Bulletin: Independent Charity Patient Assistance Programs</a> (May 21, 2014) These related special advisory bulletins provide guidance regarding patient assistance programs operated by independent charities that provide cost-sharing assistance for prescription drugs. (<a href="https://oig.hhs.gov/newsroom/news-releases/2014/charity.asp">News Release</a>)</li>

<li><a href="https://oig.hhs.gov/authorities/docs/03/050503FRCPGPharmac.pdf">Compliance Program Guidance for Pharmaceutical Manufacturers</a> (68 Fed. Reg. 23731; May 5, 2003) This guidance sets forth specific elements that pharmaceutical manufacturers should consider when developing and implementing an effective compliance program and includes a discussion of key areas of potential risk under the anti-kickback statute. </li>
</ul>


<h3>Footnotes</h3>
<p><sup>1</sup>  See section 1128B(b) of the Social Security Act.</p>
<p> <sup>2</sup>  See section 1128A(a)(5) of the Social Security Act.</p>


<!-- /Tab Interior -->
</div>



<div class="contentSeparator"></div>



<!-- Closing out Tab Divs -->
</div>
</div>





				</div><!-- leftContentInterior -->
			</div>	<!-- leftSideInterior ends -->
			<div id="rightSide">
				<!--#include file="./port-nav-pop.asp" -->
        
        
<div id="subNav">

<!--#include file="./guidance-sidebar.asp" -->
        
<div class="subNavBottom"></div>
</div><!-- subNav ends -->
<div class="clear"></div>



				<div class="clearPadding"></div>
	
			</div><!-- rightSide ends -->
			<div class="clear"></div>
		</div><!-- mainBody ends -->
	</div><!-- textReset ends -->
</div><!-- bodyContainer ends -->
<div id="footerContainer">
	<!--#include virtual="/layout/footer-top.asp" -->
</div><!-- footerContainer ends -->
<div id="footerBottomContainer">
	<!-- #include virtual="/layout/footer-bottom.asp" -->
</div><!-- footerBottomContainer -->
</body>
</html>
